DRSplus— 510(k) K192113

Substantially Equivalent

Centervue S.P.A.

FDA 510(k) clearance K192113 for DRSplus, Substantially Equivalent on 2019-11-15. Applicant: Centervue S.P.A..

Clearance details

Applicant: Centervue S.P.A.
Product code: Code MYC
Advisory panel: Ophthalmic
Date received: 2019-08-05
Decision date: 2019-11-15
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Padova, IT

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.